"Global Artificial Intelligence in Oncology Market Overview:
Global Artificial Intelligence in Oncology Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Artificial Intelligence in Oncology Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Artificial Intelligence in Oncology involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Artificial Intelligence in Oncology Market:
The Artificial Intelligence in Oncology Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Artificial Intelligence in Oncology Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Artificial Intelligence in Oncology Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Artificial Intelligence in Oncology market has been segmented into:
Software/Platform
Hardware
Services
By Application, Artificial Intelligence in Oncology market has been segmented into:
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Artificial Intelligence in Oncology market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Artificial Intelligence in Oncology market.
Top Key Players Covered in Artificial Intelligence in Oncology market are:
Azra AI
IBM Corporation
Siemens Healthineers AG
Intel Corporation
GE HealthCare
NVIDIA Corporation
Digital Diagnostics Inc.
ConcertAI
Median Technologies
PathAI
Microsoft
Zebra Medical Vision
Babylon
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Artificial Intelligence in Oncology Market by Type
4.1 Artificial Intelligence in Oncology Market Snapshot and Growth Engine
4.2 Artificial Intelligence in Oncology Market Overview
4.3 Software/Platform
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Software/Platform: Geographic Segmentation Analysis
4.4 Hardware
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Hardware: Geographic Segmentation Analysis
4.5 Services
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Services: Geographic Segmentation Analysis
Chapter 5: Artificial Intelligence in Oncology Market by Application
5.1 Artificial Intelligence in Oncology Market Snapshot and Growth Engine
5.2 Artificial Intelligence in Oncology Market Overview
5.3 Breast Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Breast Cancer: Geographic Segmentation Analysis
5.4 Lung Cancer
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Lung Cancer: Geographic Segmentation Analysis
5.5 Prostate Cancer
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Prostate Cancer: Geographic Segmentation Analysis
5.6 Colorectal Cancer
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Colorectal Cancer: Geographic Segmentation Analysis
5.7 Brain Tumor
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Brain Tumor: Geographic Segmentation Analysis
5.8 Others
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Artificial Intelligence in Oncology Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 AZRA AI
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 IBM CORPORATION
6.4 SIEMENS HEALTHINEERS AG
6.5 INTEL CORPORATION
6.6 GE HEALTHCARE
6.7 NVIDIA CORPORATION
6.8 DIGITAL DIAGNOSTICS INC.
6.9 CONCERTAI
6.10 MEDIAN TECHNOLOGIES
6.11 PATHAI
6.12 MICROSOFT
6.13 ZEBRA MEDICAL VISION
6.14 AND BABYLON
Chapter 7: Global Artificial Intelligence in Oncology Market By Region
7.1 Overview
7.2. North America Artificial Intelligence in Oncology Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Software/Platform
7.2.4.2 Hardware
7.2.4.3 Services
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Breast Cancer
7.2.5.2 Lung Cancer
7.2.5.3 Prostate Cancer
7.2.5.4 Colorectal Cancer
7.2.5.5 Brain Tumor
7.2.5.6 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Artificial Intelligence in Oncology Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Software/Platform
7.3.4.2 Hardware
7.3.4.3 Services
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Breast Cancer
7.3.5.2 Lung Cancer
7.3.5.3 Prostate Cancer
7.3.5.4 Colorectal Cancer
7.3.5.5 Brain Tumor
7.3.5.6 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Artificial Intelligence in Oncology Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Software/Platform
7.4.4.2 Hardware
7.4.4.3 Services
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Breast Cancer
7.4.5.2 Lung Cancer
7.4.5.3 Prostate Cancer
7.4.5.4 Colorectal Cancer
7.4.5.5 Brain Tumor
7.4.5.6 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Artificial Intelligence in Oncology Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Software/Platform
7.5.4.2 Hardware
7.5.4.3 Services
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Breast Cancer
7.5.5.2 Lung Cancer
7.5.5.3 Prostate Cancer
7.5.5.4 Colorectal Cancer
7.5.5.5 Brain Tumor
7.5.5.6 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Artificial Intelligence in Oncology Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Software/Platform
7.6.4.2 Hardware
7.6.4.3 Services
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Breast Cancer
7.6.5.2 Lung Cancer
7.6.5.3 Prostate Cancer
7.6.5.4 Colorectal Cancer
7.6.5.5 Brain Tumor
7.6.5.6 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Artificial Intelligence in Oncology Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Software/Platform
7.7.4.2 Hardware
7.7.4.3 Services
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Breast Cancer
7.7.5.2 Lung Cancer
7.7.5.3 Prostate Cancer
7.7.5.4 Colorectal Cancer
7.7.5.5 Brain Tumor
7.7.5.6 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Artificial Intelligence in Oncology Scope:
|
Report Data
|
Artificial Intelligence in Oncology Market
|
|
Artificial Intelligence in Oncology Market Size in 2025
|
USD XX million
|
|
Artificial Intelligence in Oncology CAGR 2025 - 2032
|
XX%
|
|
Artificial Intelligence in Oncology Base Year
|
2024
|
|
Artificial Intelligence in Oncology Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Azra AI, IBM Corporation, Siemens Healthineers AG, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI, Median Technologies, PathAI, Microsoft, Zebra Medical Vision, and Babylon.
|
|
Key Segments
|
By Type
Software/Platform
Hardware
Services
By Applications
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
|
